Abstract
1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have